secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001636422-23-000095
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q2 revenue $73.2M beats midpoint; raises FY2023 guidance
------------------------------------------------------------------------

- Total revenue $73.2M (+4% YoY) vs guidance midpoint of $72.3M.
- Adjusted EBITDA $3.5M vs guidance midpoint of $2.75M; margin ~5% (+200 bps YoY).
- Two large TEMS contracts signed: ~$50M and ~$60M, each with existing health system clients.
- FY2023 revenue guidance raised to $290.5M–$295.5M; Adjusted EBITDA raised to $10.0M–$12.0M.
- Net loss improved to $32.6M from $33.4M YoY; dollar-based retention reiterated at 102%–110%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000095/0001636422-23-000095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000095/hcat-20230808.htm
  HTML page:      https://secwatch.observer/filing/0001636422-23-000095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer